MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Assessment of new technology in deep brain stimulation technology: what are the anticipated benefits?

    C. Butson (Salt Lake City, UT, USA)

    Objective: To assess the ability of directional DBS leads and stimulation field shaping to provide more precisely targeted therapy. Background: Deep brain stimulation (DBS) has…
  • 2017 International Congress

    Personal KinetiGraph Devices Assessing Efficacy of Continuous Enteral Carbidopa/Levodopa Infusion Therapy

    J. Margolesky, C. Luca (Miami, FL, USA)

    Objective: To assess the utility of Personal KinetiGraph (PKG) devices to objectively quantify difference in motor symptoms and motor fluctuations before and after the initiation…
  • 2017 International Congress

    An Evaluation of the Parkinson’s Kinetigraph (PKG) as a Tool to Support Deep Brain Stimulation Eligibility Assessment in Patients with Parkinson’s Disease

    M. Horne, J. Volkmann, C. Sannelli, P.-P. Luyet, E. Moro (Parkville, Australia)

    Objective: To assess whether data obtained from an objective movement recording system such as the Parkinson’s KinetiGraph (PKG) could predict the motor criteria used by…
  • 2017 International Congress

    Patients’ Perspective of Physicians’ Counseling on Exercise in Parkinson’s Disease (PD)

    J.Y. Park, V. Shanker (New York, NY, USA)

    Objective: To assess if exercise counseling during appointments translates to knowledge or action in PD patients Background: Aerobic activity can improve motor function, mood, cognition,…
  • 2017 International Congress

    The influence of neurorehabilitation on Parkinson medication

    V. Tomantschger, A. Tautscher-Basnett, M. Freimueller (Hermagor, Austria)

    Objective: To investigate the influence of neurorehabilitation on the dose changes of Parkinson medication over time.  Background: In progressive disorders such as Parkinson’s disease (PD),…
  • 2017 International Congress

    Low frequency Deep Brain stimulation for Parkinson’s disease – Effect on freezing of gait.

    R. Gopalakrishnan, G. Hosurkar (Bangalore, India)

    Objective: Parkinson's disease patients who have undergone deep brain stimulation ( DBS) having freezing of gait do not show improvement with high frequency stimulation (…
  • 2017 International Congress

    Direct dopaminergic responsiveness of activity performance

    P. Hagell, G.-M. Hariz, B. Sandlund (Kristianstad, Sweden)

    Objective: To assess the direct dopaminergic responsiveness of motor and process aspects of activity performance in people with parkinsonian disorders, and to compare this to…
  • 2017 International Congress

    Treadmill training, Tai Chi, dance and more: a meta-analysis on the effectiveness of different physiotherapy modalities in Parkinson’s disease

    D. Radder, N. de Vries, M. Faber, M. van Nimwegen, S. Keus, B. Bloem (Nijmegen, Netherlands)

    Objective: Physiotherapy (PT) is widely recognized as an intervention for people with Parkinson’s disease (PD). Many controlled trials have evaluated conventional PT, and the evidence…
  • 2017 International Congress

    Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease

    A. Verma, V. Kumar, U. Singh (Allahabad, India)

    Objective: In the present study, we intended to develop novel 1,2,4 triazole as potent A(2A)AR antagonists against parkinson’s disease. Background: Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Alternative Apomorphine Challenge Test

    J.C. Martinez Castrillo, A. Alonso Canovas, C. Estevez Fraga, G. Sanchez Diez, I. Avilés Olmos, J. Lopez Sendon, P. Garcia Ruiz, L. Vela Desojo (Madrid, Spain)

    Objective: To propose a new apomorphine challenge test Background: In the standard apomorphine challenge test, the appropriate dose of apomorphine is established by incremental dosing…
  • « Previous Page
  • 1
  • …
  • 1440
  • 1441
  • 1442
  • 1443
  • 1444
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley